Jacobs Levy Equity Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.18M | Buy |
+244,533
| New | +$4.18M | 0.02% | 480 |
|
|
2024
Q4 | – | Sell |
-753,845
| Closed | -$94.1M | – | 1037 |
|
|
2024
Q3 | $94.1M | Buy |
753,845
+63,437
| +9% | +$7.92M | 0.36% | 68 |
|
|
2024
Q2 | $109M | Buy |
690,408
+110,771
| +19% | +$17.5M | 0.45% | 52 |
|
|
2024
Q1 | $75M | Buy |
579,637
+120,535
| +26% | +$15.6M | 0.34% | 73 |
|
|
2023
Q4 | $44.3M | Buy |
459,102
+61,646
| +16% | +$5.94M | 0.22% | 104 |
|
|
2023
Q3 | $48.2M | Sell |
397,456
-48,117
| -11% | -$5.83M | 0.29% | 78 |
|
|
2023
Q2 | $51M | Sell |
445,573
-36,423
| -8% | -$4.17M | 0.29% | 85 |
|
|
2023
Q1 | $66.4M | Buy |
481,996
+6,095
| +1% | +$840K | 0.41% | 56 |
|
|
2022
Q4 | $61.7M | Sell |
475,901
-26,292
| -5% | -$3.41M | 0.42% | 59 |
|
|
2022
Q3 | $55.5M | Buy |
502,193
+66,383
| +15% | +$7.34M | 0.44% | 52 |
|
|
2022
Q2 | $32.7M | Sell |
435,810
-2,235
| -0.5% | -$168K | 0.25% | 110 |
|
|
2022
Q1 | $34.2M | Buy |
438,045
+9,311
| +2% | +$727K | 0.23% | 109 |
|
|
2021
Q4 | $38.6M | Buy |
428,734
+330,949
| +338% | +$29.8M | 0.26% | 102 |
|
|
2021
Q3 | $9.04M | Buy |
97,785
+4,835
| +5% | +$447K | 0.06% | 321 |
|
|
2021
Q2 | $7.23M | Buy |
92,950
+3,953
| +4% | +$307K | 0.05% | 365 |
|
|
2021
Q1 | $6.63M | Buy |
+88,997
| New | +$6.63M | 0.05% | 373 |
|
|
2020
Q3 | – | Sell |
-2,943
| Closed | -$472K | – | 1102 |
|
|
2020
Q2 | $472K | Buy |
+2,943
| New | +$472K | 0.01% | 797 |
|
|
2016
Q3 | – | Sell |
-18,300
| Closed | -$349K | – | 1122 |
|
|
2016
Q2 | $349K | Buy |
+18,300
| New | +$349K | 0.01% | 849 |
|